建立一种高浓度成像检测方法,用于检测由两种方案分化而来的 hiPSC 神经元中 tau 的聚集情况,以便对化合物和遗传扰动进行常规评估。

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Lamiaa Bahnassawy , Nathalie Nicolaisen , Christopher Untucht , Benjamin Mielich-Süss , Lydia Reinhardt , Janina S. Ried , Martina P. Morawe , Daniela Geist , Anja Finck , Elke Käfer , Jürgen Korffmann , Matthew Townsend , Brinda Ravikumar , Viktor Lakics , Miroslav Cik , Peter Reinhardt
{"title":"建立一种高浓度成像检测方法,用于检测由两种方案分化而来的 hiPSC 神经元中 tau 的聚集情况,以便对化合物和遗传扰动进行常规评估。","authors":"Lamiaa Bahnassawy ,&nbsp;Nathalie Nicolaisen ,&nbsp;Christopher Untucht ,&nbsp;Benjamin Mielich-Süss ,&nbsp;Lydia Reinhardt ,&nbsp;Janina S. Ried ,&nbsp;Martina P. Morawe ,&nbsp;Daniela Geist ,&nbsp;Anja Finck ,&nbsp;Elke Käfer ,&nbsp;Jürgen Korffmann ,&nbsp;Matthew Townsend ,&nbsp;Brinda Ravikumar ,&nbsp;Viktor Lakics ,&nbsp;Miroslav Cik ,&nbsp;Peter Reinhardt","doi":"10.1016/j.slasd.2023.12.009","DOIUrl":null,"url":null,"abstract":"<div><p>Aberrant protein aggregation is a pathological cellular hallmark of many neurodegenerative diseases, such as Alzheimer's disease (AD) and frontotemporal dementia (FTD), where the tau protein is aggregating, forming neurofibrillary tangles (NFTs), and propagating from neuron to neuron. These processes have been linked to disease progression and a decline in cognitive function. Various therapeutic approaches aim at the prevention or reduction of tau aggregates in neurons. Human induced pluripotent stem cells (hiPSCs) are a very valuable tool in neuroscience discovery, as they offer access to potentially unlimited amounts of cell types that are affected in disease, including cortical neurons, for <em>in vitro</em> studies. We have generated an <em>in vitro</em> model for tau aggregation that uses hiPSC – derived neurons expressing an aggregation prone, fluorescently tagged version of the human tau protein after lentiviral transduction. Upon addition of tau seeds in the form of recombinant sonicated paired helical filaments (sPHFs), the neurons show robust, disease-like aggregation of the tau protein. The model was developed as a plate-based high content screening assay coupled with an image analysis algorithm to evaluate the impact of small molecules or genetic perturbations on tau. We show that the assay can be used to evaluate small molecules or screen targeted compound libraries. Using siRNA-based gene knockdown, genes of interest can be evaluated, and we could show that a targeted gene library can be screened, by screening nearly 100 deubiquitinating enzymes (DUBs) in that assay. The assay uses an imaging-based readout, a relatively short timeline, quantifies the extent of tau aggregation, and also allows the assessment of cell viability. Furthermore, it can be easily adapted to different hiPSC lines or neuronal subtypes. Taken together, this complex and highly relevant approach can be routinely applied on a weekly basis in the screening funnels of several projects and generates data with a turnaround time of approximately five weeks.</p></div>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2472555223000990/pdfft?md5=34d92141e506ff12fc2f7f9b45f750eb&pid=1-s2.0-S2472555223000990-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Establishment of a high-content imaging assay for tau aggregation in hiPSC-derived neurons differentiated from two protocols to routinely evaluate compounds and genetic perturbations\",\"authors\":\"Lamiaa Bahnassawy ,&nbsp;Nathalie Nicolaisen ,&nbsp;Christopher Untucht ,&nbsp;Benjamin Mielich-Süss ,&nbsp;Lydia Reinhardt ,&nbsp;Janina S. Ried ,&nbsp;Martina P. Morawe ,&nbsp;Daniela Geist ,&nbsp;Anja Finck ,&nbsp;Elke Käfer ,&nbsp;Jürgen Korffmann ,&nbsp;Matthew Townsend ,&nbsp;Brinda Ravikumar ,&nbsp;Viktor Lakics ,&nbsp;Miroslav Cik ,&nbsp;Peter Reinhardt\",\"doi\":\"10.1016/j.slasd.2023.12.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Aberrant protein aggregation is a pathological cellular hallmark of many neurodegenerative diseases, such as Alzheimer's disease (AD) and frontotemporal dementia (FTD), where the tau protein is aggregating, forming neurofibrillary tangles (NFTs), and propagating from neuron to neuron. These processes have been linked to disease progression and a decline in cognitive function. Various therapeutic approaches aim at the prevention or reduction of tau aggregates in neurons. Human induced pluripotent stem cells (hiPSCs) are a very valuable tool in neuroscience discovery, as they offer access to potentially unlimited amounts of cell types that are affected in disease, including cortical neurons, for <em>in vitro</em> studies. We have generated an <em>in vitro</em> model for tau aggregation that uses hiPSC – derived neurons expressing an aggregation prone, fluorescently tagged version of the human tau protein after lentiviral transduction. Upon addition of tau seeds in the form of recombinant sonicated paired helical filaments (sPHFs), the neurons show robust, disease-like aggregation of the tau protein. The model was developed as a plate-based high content screening assay coupled with an image analysis algorithm to evaluate the impact of small molecules or genetic perturbations on tau. We show that the assay can be used to evaluate small molecules or screen targeted compound libraries. Using siRNA-based gene knockdown, genes of interest can be evaluated, and we could show that a targeted gene library can be screened, by screening nearly 100 deubiquitinating enzymes (DUBs) in that assay. The assay uses an imaging-based readout, a relatively short timeline, quantifies the extent of tau aggregation, and also allows the assessment of cell viability. Furthermore, it can be easily adapted to different hiPSC lines or neuronal subtypes. Taken together, this complex and highly relevant approach can be routinely applied on a weekly basis in the screening funnels of several projects and generates data with a turnaround time of approximately five weeks.</p></div>\",\"PeriodicalId\":2,\"journal\":{\"name\":\"ACS Applied Bio Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2472555223000990/pdfft?md5=34d92141e506ff12fc2f7f9b45f750eb&pid=1-s2.0-S2472555223000990-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Bio Materials\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2472555223000990\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2472555223000990","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

摘要

蛋白异常聚集是阿尔茨海默病(AD)和额颞叶痴呆(FTD)等许多神经退行性疾病的病理细胞标志,其中 tau 蛋白正在聚集,形成神经纤维缠结(NFT),并在神经元之间传播。这些过程与疾病进展和认知功能下降有关。各种治疗方法都旨在预防或减少神经元中的tau聚集。人类诱导多能干细胞(hiPSCs)是神经科学发现中非常有价值的工具,因为它们为体外研究提供了可能无限量的受疾病影响的细胞类型,包括皮质神经元。我们利用 hiPSC 衍生的神经元,经过慢病毒转导后表达易发生聚集的荧光标记版人类 tau 蛋白,生成了 tau 聚集的体外模型。在加入重组声化成对螺旋丝(sPHFs)形式的 tau 种子后,神经元显示出强大的、类似疾病的 tau 蛋白聚集。该模型被开发为一种基于平板的高含量筛选测定法,并与图像分析算法相结合,以评估小分子或基因扰动对 tau 的影响。我们的研究表明,该试验可用于评估小分子或筛选靶向化合物库。通过使用基于 siRNA 的基因敲除,可以评估感兴趣的基因,我们还可以通过在该测定中筛选近 100 种去泛素化酶 (DUB),证明可以筛选靶向基因库。该测定使用基于成像的读数,时间相对较短,可量化 tau 的聚集程度,还能评估细胞活力。此外,它还能很容易地适用于不同的 hiPSC 株系或神经元亚型。总之,这种复杂而高度相关的方法可以每周在多个项目的筛选漏斗中常规应用,产生数据的周转时间约为五周。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Establishment of a high-content imaging assay for tau aggregation in hiPSC-derived neurons differentiated from two protocols to routinely evaluate compounds and genetic perturbations

Aberrant protein aggregation is a pathological cellular hallmark of many neurodegenerative diseases, such as Alzheimer's disease (AD) and frontotemporal dementia (FTD), where the tau protein is aggregating, forming neurofibrillary tangles (NFTs), and propagating from neuron to neuron. These processes have been linked to disease progression and a decline in cognitive function. Various therapeutic approaches aim at the prevention or reduction of tau aggregates in neurons. Human induced pluripotent stem cells (hiPSCs) are a very valuable tool in neuroscience discovery, as they offer access to potentially unlimited amounts of cell types that are affected in disease, including cortical neurons, for in vitro studies. We have generated an in vitro model for tau aggregation that uses hiPSC – derived neurons expressing an aggregation prone, fluorescently tagged version of the human tau protein after lentiviral transduction. Upon addition of tau seeds in the form of recombinant sonicated paired helical filaments (sPHFs), the neurons show robust, disease-like aggregation of the tau protein. The model was developed as a plate-based high content screening assay coupled with an image analysis algorithm to evaluate the impact of small molecules or genetic perturbations on tau. We show that the assay can be used to evaluate small molecules or screen targeted compound libraries. Using siRNA-based gene knockdown, genes of interest can be evaluated, and we could show that a targeted gene library can be screened, by screening nearly 100 deubiquitinating enzymes (DUBs) in that assay. The assay uses an imaging-based readout, a relatively short timeline, quantifies the extent of tau aggregation, and also allows the assessment of cell viability. Furthermore, it can be easily adapted to different hiPSC lines or neuronal subtypes. Taken together, this complex and highly relevant approach can be routinely applied on a weekly basis in the screening funnels of several projects and generates data with a turnaround time of approximately five weeks.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信